Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience

Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11.


Coronavirus disease 19 (COVID‐19) has posed unparalleled challenges for health care communities, the general population, and in particular, for patients suffering from various comorbidities. Patients with hematological disorders, both benign and malignant need special attention during this crisis time to ensure uninterrupted delivery of optimal care (Sahu & Siddiqui, 2020).

Keywords: anaemia; coronavirus; pandemic; sickle cell anaemia; viruses.

Publication types

  • Letter
  • Review

MeSH terms

  • Adult
  • Anemia, Sickle Cell / complications
  • Anemia, Sickle Cell / therapy*
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / complications*
  • Disease Management
  • Female
  • Humans
  • Male
  • Pandemics
  • Pneumonia, Viral / complications*
  • SARS-CoV-2
  • Young Adult